| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $119.0M | +36.0% |
| SG&A Expense | $59.2M | +19.8% |
| Operating Income | -$178.2M | -30.2% |
| Interest Expense | $4.5M | +104.2% |
| Pre-tax Income | -$153.5M | -30.5% |
| Income Tax | $1.6M | +104.4% |
| Net Income | -$155.1M | -30.9% |
| EPS (Basic) | -$2.30 | +0.9% |
| EPS (Diluted) | -$2.30 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $165.1M | -25.0% |
| Current Assets | $201.3M | -23.0% |
| Total Assets | $213.7M | -22.6% |
| Current Liabilities | $34.0M | +73.5% |
| Long-term Debt | $30.2M | +4.9% |
| Total Liabilities | $59.0M | +17.4% |
| Stockholders' Equity | $154.7M | -31.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$119.2M | -22.4% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $63.8M | -63.3% |
| Free Cash Flow | -$119.2M | -22.3% |
| +0.9% |